Market Overview:
The global hyperhidrosis treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of hyperhidrosis, rising awareness about available treatments, and technological advancements in the field of hyperhidrosis treatment. The global hyperhidrosis treatment market is segmented on the basis of type, application, and region.Geographically , North America dominates themarketfollowedby Europeand Asia Pacific .
Product Definition:
Hyperhidrosis Treatment is a medical procedure that helps to stop excessive sweating.
Iontophoresis- This treatment uses an electric current to help stop the sweat glands from producing sweat.
Botox- This treatment uses Botulinum toxin (Botox) to help paralyze the sweat glands and stop them from producing sweat.
Anticholinergic drugs- These are medications that help to block the action of acetylcholine, which is a chemical that helps stimulate the production of sweat.
Axillary Hyperhidrosis:
Axillary hyperhidrosis is a condition, in which there is excessive production of sweat under the armpit. The excessive sweating may lead to discomfort and social avoidance. Hyperhidrosis can be treated by using an antiperspirant or deodorant, however; it cannot be cured completely.
Palmar Hyperhidrosis:
Palmar hyperhidrosis is a condition, where the excessive sweating of hands and feet occurs due to hot temperatures. It is also known as palmoplantar hyperhidrosis. This excessive sweating can be treated by using certain medicines which are prescribed by doctors. The major symptoms associated with this disease includes hand and foot sweat when exposed to warm temperatures, no matter how much the person sweats or how long he/she remains without any physical activity.
Application Insights:
Based on application, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment dominated the overall hyperhidrosis treatment market in 2017 due to factors such as high prevalence of diabetes and other disorders that lead to excessive sweating. In addition, there is a significant increase in number of surgeries performed for palmoplantar hyperhidrosis due to commercialization of non-invasive procedures such as Radiofrequency Ablation (RFA).
The others segment includes fitness centers, spas/lifestyle clubs and dermatology offices. These segments are expected to witness lucrative growth over the forecast period owing to increasing awareness about health & hygiene among consumers globally. Furthermore, these segments have adopted various marketing strategies such as advertising campaigns by collaborating with popular lifestyle brands for promoting their services more effectively among consumers.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the availability of technologically advanced products, high patient awareness levels coupled with a higher healthcare expenditure in this region as compared to others. The Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing disposable income and rising healthcare expenditure by government and private sectors. Moreover, an increase in awareness about hyperhidrosis conditions and its treatment options will drive regional growth further.
Major players operating include but are not limited too; BK Medical Corporation; Boston Scientific Corporation; Dr Reddy's Laboratories Ltd.; Merz Pharma GmbH & Co., KGaA.; Novartis AG; Pfizer Inc.; Roche Holding Ltd.
Growth Factors:
- Increasing prevalence of hyperhidrosis
- Growing awareness about the treatment options for hyperhidrosis
- Availability of new and advanced treatment options for hyperhidrosis
- Rising number of clinical studies on hyperhidrosis treatments
- increasing investment in research and development for novel therapies forhyperhidrosis
Scope Of The Report
Report Attributes
Report Details
Report Title
Hyperhidrosis Treatment Market Research Report
By Type
Axillary Hyperhidrosis, Palmar Hyperhidrosis, Plantar Hyperhidrosis, Others
By Application
Hospitals, Ambulatory Surgical Centers, Others
By Companies
GlaxoSmithKline, Allergan, Ulthera, TheraVida, Dermira, Revance Therapeutics, Miramar Labs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Hyperhidrosis Treatment Market Report Segments:
The global Hyperhidrosis Treatment market is segmented on the basis of:
Types
Axillary Hyperhidrosis, Palmar Hyperhidrosis, Plantar Hyperhidrosis, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Allergan
- Ulthera
- TheraVida
- Dermira
- Revance Therapeutics
- Miramar Labs
Highlights of The Hyperhidrosis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Axillary Hyperhidrosis
- Palmar Hyperhidrosis
- Plantar Hyperhidrosis
- Others
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hyperhidrosis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best treatment for hyperhidrosis will vary depending on the individual's specific symptoms and medical history. However, some common treatments for hyperhidrosis include prescription medications such as clonidine or adapalene, over-the-counter topical treatments such as antiperspirants or deodorants, and laser therapy.
Some of the key players operating in the hyperhidrosis treatment market are GlaxoSmithKline, Allergan, Ulthera, TheraVida, Dermira, Revance Therapeutics, Miramar Labs.
The hyperhidrosis treatment market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hyperhidrosis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hyperhidrosis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hyperhidrosis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hyperhidrosis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hyperhidrosis Treatment Market Size & Forecast, 2018-2028
4.5.1 Hyperhidrosis Treatment Market Size and Y-o-Y Growth
4.5.2 Hyperhidrosis Treatment Market Absolute $ Opportunity
Chapter 5 Global Hyperhidrosis Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hyperhidrosis Treatment Market Size Forecast by Type
5.2.1 Axillary Hyperhidrosis
5.2.2 Palmar Hyperhidrosis
5.2.3 Plantar Hyperhidrosis
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hyperhidrosis Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hyperhidrosis Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hyperhidrosis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hyperhidrosis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hyperhidrosis Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Hyperhidrosis Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hyperhidrosis Treatment Market Size Forecast by Type
9.6.1 Axillary Hyperhidrosis
9.6.2 Palmar Hyperhidrosis
9.6.3 Plantar Hyperhidrosis
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hyperhidrosis Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hyperhidrosis Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Hyperhidrosis Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hyperhidrosis Treatment Market Size Forecast by Type
10.6.1 Axillary Hyperhidrosis
10.6.2 Palmar Hyperhidrosis
10.6.3 Plantar Hyperhidrosis
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hyperhidrosis Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hyperhidrosis Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hyperhidrosis Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hyperhidrosis Treatment Market Size Forecast by Type
11.6.1 Axillary Hyperhidrosis
11.6.2 Palmar Hyperhidrosis
11.6.3 Plantar Hyperhidrosis
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hyperhidrosis Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hyperhidrosis Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Hyperhidrosis Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hyperhidrosis Treatment Market Size Forecast by Type
12.6.1 Axillary Hyperhidrosis
12.6.2 Palmar Hyperhidrosis
12.6.3 Plantar Hyperhidrosis
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hyperhidrosis Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hyperhidrosis Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hyperhidrosis Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hyperhidrosis Treatment Market Size Forecast by Type
13.6.1 Axillary Hyperhidrosis
13.6.2 Palmar Hyperhidrosis
13.6.3 Plantar Hyperhidrosis
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hyperhidrosis Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hyperhidrosis Treatment Market: Competitive Dashboard
14.2 Global Hyperhidrosis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Allergan
14.3.3 Ulthera
14.3.4 TheraVida
14.3.5 Dermira
14.3.6 Revance Therapeutics
14.3.7 Miramar Labs
